New York A 1323: Relates to synthetic cannabinoids, synthetic cannabinoid analog and substituted cathinones and prohibiting the production and sale thereof
Status: REFERRED TO HEALTH (as of 2022-01-05)
State: New York · Session: 2021-2022 · Bill: A 1323
Sponsors: MAGNARELLI
Bill Text
STATE OF NEW YORK ________________________________________________________________________ 1323 2021-2022 Regular Sessions IN ASSEMBLY January 8, 2021 ___________ Introduced by M. of A. MAGNARELLI, BARCLAY, COOK, SIMON, PEOPLES-STOKES, GALEF, OTIS, WOERNER, JEAN-PIERRE -- Multi-Sponsored by -- M. of A. HYNDMAN, RAMOS -- read once and referred to the Committee on Health AN ACT to amend the public health law, the penal law and the general business law, in relation to synthetic cannabinoids, synthetic canna- binoid analog and substituted cathinones and prohibiting the production and sale thereof The People of the State of New York, represented in Senate and Assem- bly, do enact as follows: 1 Section 1. Section 3302 of the public health law is amended by adding 2 three new subdivisions 44, 45 and 46 to read as follows: 3 44. "Synthetic cannabinoid" means any chemical compound that is chemi- 4 cally synthesized and: 5 (a) has been demonstrated to have a binding activity at one or more 6 cannabinoid receptors; or 7 (b) is a chemical isomer, salt or salt of an isomer of a compound that 8 has been demonstrated to have binding activity at one or more cannabi- 9 noid receptors; or 10 (c) has been designated in regulation by the commissioner as being a 11 synthetic cannabinoid or synthetic cannabinoid analog. 12 "Synthetic cannabinoid" does not include any product that has been 13 approved for medical use by the United States Food and Drug Adminis- 14 tration. 15 45. "Synthetic cannabinoid analog" means any chemical that is substan- 16 tially similar in chemical structure to a chemical compound that has 17 been determined to have binding activity at one or more cannabinoid 18 receptors. It does not include any products that have been approved for 19 medical use by the United States Food and Drug Administration. 20 46. "Substituted cathinone" means any chemical compound that is chemi- 21 cally synthesized and: EXPLANATION--Matter in (underscored) is new; matter in bracketsitalics [ ] is old law to be omitted. LBD01776-01-1 A. 1323 2 1 (a) is a compound listed in paragraph five, eight or nine of subdivi- 2 sion (f) of Schedule I of section thirty-three hundred six of this arti- 3 cle, or 4 (b) has been designated in regulation by the commissioner as having a 5 chemical structure derivative of cathinone, or 6 (c) any compound, other than buproprion, that is structurally derived 7 from 2-amino-1-phenyl-1-propanone by modification in any of the follow- 8 ing ways: 9 (i) by substitution in the phenyl ring to any extent with alkyl, 10 alkoxy, alkylenedioxy, haloalkyl, or halide substituents, whether or not 11 further substituted in the phenyl ring by one or more other univalent 12 substituents; 13 (ii) by substitution at the three-position with an alkyl substitutent; 14 (iii) by substitution at the nitrogen atom with alkyl or dialkyl 15 groups, or by inclusion of the nitrogen atom in a cyclic structure. 16 § 2. Subdivisions 5 and 6 of section 220.00 of the penal law, subdivi- 17 sion 5 as amended by chapter 537 of the laws of 1998, and subdivision 6 18 as amended by chapter 1051 of the laws of 1973, are amended to read as 19 follows: 20 5. "Controlled substance" means any substance listed in schedule I, 21 II, III, IV or V of section thirty-three hundred six of the public 22 health law other than marihuana, but including concentrated cannabis as 23 defined in paragraph (a) of subdivision four of section thirty-three 24 hundred two of such law, and substituted cathinones as defined in 25 .section thirty-three hundred two of the public health law 26 6. "Marihuana" means "marihuana" [ ] "concentrated cannabis"or , , 27 as those terms"synthetic cannabinoid" or "synthetic cannabinoid analog" 28 are defined in section thirty-three hundred two of the public health 29 law. 30 § 3. The general business law is amended by adding a new section 399- 31 hh to read as follows: 32 § 399-hh. Sale of synthetic cannabinoid, synthetic cannabinoid analog 33 and substituted cathinone prohibited. 1. For purposes of this section, 34 "synthetic cannabinoid" means any substance defined by subdivision 35 forty-four or forty-five of section thirty-three hundred two of the 36 public health law and "substituted cathinone" means any substance 37 defined by subdivision forty-six of section thirty-three hundred two of 38 the public health law. 39 2. No person, corporation, partnership or limited liability company 40 shall knowingly sell or offer for sale any form of synthetic cannabi- 41 noid, substituted cathinone or any other substance intended to act as or 42 advertised as an alternative form of a controlled substance. No person, 43 corporation, partnership or limited liability company shall offer any 44 substance for sale where there has been an explicit or implied claim 45 made by the selling party that the substance sold will mimic or approxi- 46 mate the same effects of cannabinoid, synthetic cannabinoid, substituted 47 cathinone or any other substa
View New York A 1323 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.